Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription 05.10.2026 4 Am J Gastroenterol 8 Anticancer Res 1 Biochem Biophys Res Commun 1 BMC Gastroenterol 2 Cancer Res 1 Endoscopy 1 Eur Radiol 1 Gastroenterology 2 Gut 2 Hepatology 1 J Gastroenterol 4 J Gastroenterol Hepatol 2 J Hepatol 1 Lancet 4 PLoS One 3 Proc Natl Acad Sci U S A 1 Radiology 5 Semin Liver Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. BOWLUS CL, Bittencourt PL, Bobat B, Gulamhusein A, et al
   Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective.
   Am J Gastroenterol. 2026;121:2385-2392.
   PubMed         Abstract available
   
   
2. REZAEE-ZAVAREH MS, Karimi-Sari H, Parhizkar Roudsari P, Khattab O, et al
   Antibiotic Use Linked to Worse Outcomes in Patients With Gastrointestinal and Liver Cancer on Immune Checkpoint Inhibitors: A Meta-Analysis.
   Am J Gastroenterol. 2026;121:2562-2574.
   PubMed         Abstract available
   
   
3. GUNALAN SZ, Ni Law MS, Kua YX, Yu Z, et al
   Imaging Based Modalities for Identifying "At Risk" MASH. A Diagnostic Test Meta-analysis.
   Am J Gastroenterol. 2026 Jan 13. doi: 10.14309/ajg.0000000000003919.
   PubMed         Abstract available
   
   
4. JAYABALAN D, Dhakal S, Chandra J, Fasser DA, et al
   The Impact of Body Weight Change on Liver Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Across Various Histological Endpoints: A Systematic Review and Meta-Analysis.
   Am J Gastroenterol. 2026;121:2449-2464.
   PubMed         Abstract available
   
   

   
   Anticancer Res

5. CICOLANI A, Chiarini L, Goglia M, Giancola ML, et al
   Surgical Resection of Metachronous Liver Metastases in Non-colorectal Non-neuroendocrine Gastrointestinal Cancers: Systematic Review and Meta-analysis.
   Anticancer Res. 2026;46:5349-5358.
   PubMed         Abstract available
   
   
6. ISHIKAWA T, Itoh S, Kitamura Y, Iseda N, et al
   Prognostic Significance of PET- SUV(max) in Patients Undergoing Resection of Hepatocellular Carcinoma >3 cm: A Retrospective Analysis.
   Anticancer Res. 2026;46:5577-5588.
   PubMed         Abstract available
   
   
7. ARIZONO M, Furukawa K, Tsunematsu M, Yamahata Y, et al
   Post-hepatectomy-related DIC Predicts Poor Survival After Resection for Colorectal Liver Metastases.
   Anticancer Res. 2026;46:5599-5608.
   PubMed         Abstract available
   
   
8. YOSHIDA K, Kubo I, Kiyomi A, Homma Y, et al
   Clinical Determinants Influencing First-line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma in Japan.
   Anticancer Res. 2026;46:5589-5597.
   PubMed         Abstract available
   
   
9. LUCCHETTI J, Cimini P, Angotti L, Barnini G, et al
   From Genomic Insight to Clinical Impact: Dramatic Response in RET Fusion-positive Pancreatic Cancer.
   Anticancer Res. 2026;46:5751-5757.
   PubMed         Abstract available
   
   
10. CRISTAUDO AT, Morris DL
    Computational Modelling of CEA-CEAR Receptor Occupancy for Anti-CEA Therapy in Colorectal Liver Metastasis.
    Anticancer Res. 2026;46:5411-5419.
    PubMed         Abstract available
    
    
11. YAMANE T, Masuda T, Nagayama Y, Adachi Y, et al
    Multidisciplinary Treatment With Repeated Thermal Ablation for Multisite Metastatic Colon Cancer in an Elderly Patient.
    Anticancer Res. 2026;46:5789-5797.
    PubMed         Abstract available
    
    
12. KAWATE Y, Kitano Y, Kai K, Uemura S, et al
    Well-differentiated SMARCB1-deficient Pancreatic Malignancy With Indolent Liver Metastases.
    Anticancer Res. 2026;46:5781-5787.
    PubMed         Abstract available
    
    

    
    Biochem Biophys Res Commun

13. LEE S, Na HJ, Park JK, Kim WS, et al
    LXRalpha deficiency promotes hepatic tumor development in nonalcoholic fatty liver disease and alters Akt/Gsk3beta/beta-catenin signaling.
    Biochem Biophys Res Commun. 2026;838:154647.
    PubMed         Abstract available
    
    

    
    BMC Gastroenterol

14. ZHANG J, Liang Q, Xu X, Wang P, et al
    Integrating WGCNA and machine learning to identify and validate key biomarkers in MASLD.
    BMC Gastroenterol. 2026;26:592.
    PubMed         Abstract available
    
    

    
    Cancer Res

15. YAO X, Wu B, Yang C, Lin Z, et al
    Placenta-Related PEG10 Inhibits mRNA Decay to Promote Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Cancer Res. 2026 Oct 2. doi: 10.1158/0008-5472.CAN-26-0490.
    PubMed         Abstract available
    
    
16. YAN Z, Wu D, Wu J, Shi C, et al
    MYC-Dependent rRNA Catabolism Stress Dictates Survival Heterogeneity of Hepatocellular Carcinoma Cells Under Glutamine Deprivation.
    Cancer Res. 2026 Sep 29. doi: 10.1158/0008-5472.CAN-26-0575.
    PubMed         Abstract available
    
    

    
    Endoscopy

17. RIZZATTI G, Palumbo G, Tripodi G, Termite F, et al
    Detective flow imaging-assisted endoscopic ultrasound-guided radiofrequency ablation of hepatocellular carcinoma adjacent to the inferior vena cava.
    Endoscopy. 2026 Sep 28. doi: 10.1055/a-2954-0511.
    PubMed        
    
    

    
    Eur Radiol

18. SANDRASEGARAN K, Shah AS, Thompson CP, Jayasekera CR, et al
    Correction: Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)?
    Eur Radiol. 2026 Sep 30. doi: 10.1007/s00330-026-12878.
    PubMed        
    
    

    
    Gastroenterology

19. JIANG L, Dai Z, Zhu C
    An Unexpected Cause of Severe Steatohepatitis in a Young Male.
    Gastroenterology. 2026 Sep 30:S0016-5085(26)07328.
    PubMed         Abstract available
    
    

    
    Gut

20. CHEN CL, Yang WS
    GLP-1 receptor agonists versus DPP-4 inhibitors after curative resection of hepatocellular carcinoma in patients with type 2 diabetes.
    Gut. 2026 Sep 29:gutjnl-2026-339889. doi: 10.1136/gutjnl-2026-339889.
    PubMed        
    
    
21. LURJE I, Horn P, Guillot A, Uluk D, et al
    Hypothermic oxygenated and normothermic machine perfusion mitigate innate systemic and hepatic inflammation after liver transplantation.
    Gut. 2026 Sep 29:gutjnl-2026-338907. doi: 10.1136/gutjnl-2026-338907.
    PubMed         Abstract available
    
    

    
    Hepatology

22. RAO JS, Shetty A, Ramachandran S, Steer CJ, et al
    Hepatogenesis through interspecies chimerism - An immunological path distinct from xenotransplantation.
    Hepatology. 2026 Oct 2. doi: 10.1097/HEP.0000000000001880.
    PubMed        
    
    
23. YASAKA TM, Afrin S, Chen PY, Molina LM, et al
    TESERA: morphologic subtyping and prognostic stratification of hepatocellular carcinoma from H&E whole-slide images.
    Hepatology. 2026 Oct 2. doi: 10.1097/HEP.0000000000001879.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

24. KUO CC, Chen CH, Kuo HT, Lai CC, et al
    Clinical outcomes of lean metabolic dysfunction-associated steatotic liver disease by phenotypic subtypes.
    J Gastroenterol. 2026;61:1471-1482.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

25. ABBARH S, Sawaf B, Cerqueira TL, Huttner HB, et al
    Association of Aspirin With Improved Clinical Outcomes and Survival in Patients With Compensated Cirrhosis: A Propensity Score-Matched Study of 25 782 Individuals.
    J Gastroenterol Hepatol. 2026 Oct 1. doi: 10.1111/jgh.70780.
    PubMed         Abstract available
    
    
26. OUCHI K, Ninomiya M, Tsuruoka M, Inoue J, et al
    Atezolizumab Plus Bevacizumab Treatment for Patients With Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer B2 Stage.
    J Gastroenterol Hepatol. 2026 Sep 28. doi: 10.1111/jgh.70765.
    PubMed         Abstract available
    
    
27. WU C, Gao J, Gao B, Wang K, et al
    Demethylzeylasteral Targets the Sp1/AGAP2 Axis to Impair Autophagic Flux and Induce Apoptosis in Hepatic Stellate Cells.
    J Gastroenterol Hepatol. 2026 Sep 27. doi: 10.1111/jgh.70778.
    PubMed         Abstract available
    
    
28. LEE J, Cha JH, Cho HS, Yang H, et al
    PNPLA3 Is Associated With Hepatocellular Carcinoma, While a Five-Variant Polygenic Risk Score Shows Limited Discrimination in Korean Patients With MASLD.
    J Gastroenterol Hepatol. 2026 Sep 27. doi: 10.1111/jgh.70762.
    PubMed         Abstract available
    
    

    
    J Hepatol

29. WU F, Wu D, Ren Y, Huang Y, et al
    Corrigendum to: 'Generation of hepatobiliary organoids from human induced pluripotent stem cells' [J Hepatol (2019) 70 (6):1145-1158].
    J Hepatol. 2026 Sep 30:S0168-8278(26)02896-5. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
30. JOHN BV, Camardo M, Singal AG, Parikh ND, et al
    Multi-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study.
    J Hepatol. 2026 Sep 26:S0168-8278(26)02904-1. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    

    
    Lancet

31. GOEL A, Rungta S, Kumar V, Shalimar, et al
    8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.
    Lancet. 2026 Sep 30:S0140-6736(26)01380-2. doi: 10.1016/S0140-6736(26)01380.
    PubMed         Abstract available
    
    

    
    PLoS One

32. VARUGHESE S, Huang M, Savige J
    The population frequency of predicted pathogenic variants in the genes associated with Autosomal Dominant Polycystic Liver Disease (ADPLD) and kidney cysts.
    PLoS One. 2026;21:e0348109.
    PubMed         Abstract available
    
    
33. AN R, Hou S, Hong M, Zhen J, et al
    FABP5 regulates an immunosuppressive microenvironment in hepatocellular carcinoma through the NF-kappaB/PD-L1 axis.
    PLoS One. 2026;21:e0356359.
    PubMed         Abstract available
    
    
34. SHIMAGAKI T, Maeda A, Harima T, Sakai A, et al
    Association between the preoperative C-reactive protein-albumin-lymphocyte index and prognosis after hepatic resection for hepatocellular carcinoma.
    PLoS One. 2026;21:e0358776.
    PubMed         Abstract available
    
    
35. REZAYEE H, Fahmidehkar MA, Beheshti F, Ghoryani M, et al
    Protective effects of Crocin on hepatic steatosis, oxidative stress, and lipid profile in an animal model of non-alcoholic fatty liver disease.
    PLoS One. 2026;21:e0357768.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

36. NUOVO GJ, Heineman TC, Tili E, Croce CM, et al
    MicroRNA-driven regulation of immunosuppressive microenvironment in hepatocellular carcinoma.
    Proc Natl Acad Sci U S A. 2026;123:e2618249123.
    PubMed         Abstract available
    
    
37. YU L, Ajiro M, Majerciak V, Lobanov A, et al
    SRSF3 plays a key role in liver cancer sex disparity by facilitating hepatocyte expression of ERalpha and FOXA.
    Proc Natl Acad Sci U S A. 2026;123:e2536317123.
    PubMed         Abstract available
    
    
38. KE M, Kim JW, Xu M, Wang J, et al
    Desulfinylation of the deubiquitinase USP7 by SRXN1 attenuates oxidative acute liver injury.
    Proc Natl Acad Sci U S A. 2026;123:e2620180123.
    PubMed         Abstract available
    
    

    
    Radiology

39. HAIDEY J, Qian XJ, Wilson MP, Low G, et al
    Case 354.
    Radiology. 2026;320:e260544.
    PubMed         Abstract available
    
    

    
    Semin Liver Dis

40. MA R, Meng H, Chen X, Shen H, et al
    Neutrophils in Liver Diseases: Functions and Challenging Therapies.
    Semin Liver Dis. 2026;46:89-102.
    PubMed         Abstract available
    
    
41. FENG T, Li J, Ma X, Ye J, et al
    Toward Precision Medicine in MASLD: Evolution of Disease Subtyping.
    Semin Liver Dis. 2026;46:196-213.
    PubMed         Abstract available
    
    
42. THOMPSON K, Veeramachaneni H, Subramanian R
    Advances in Extracorporeal Liver Support.
    Semin Liver Dis. 2026;46:171-182.
    PubMed         Abstract available
    
    
43. KELLEY EE, Woodward OM, Khoo NKH
    Elevated Uric Acid and Metabolic Dysfunction-Associated Steatotic Liver Disease Progression: Where There's Smoke, is There Fire?
    Semin Liver Dis. 2026;46:116-134.
    PubMed         Abstract available
    
    
44. SANDHU S, Goel A
    Advances in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Semin Liver Dis. 2026;46:103-115.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum